Skip to main content
Premium Trial:

Request an Annual Quote

EMBL Licenses IMMD s KeyMolnet Bioinformatics Platform

NEW YORK, Dec. 22 (GenomeWeb News) - The European Molecular Biology Laboratory has licensed the KeyMolnet pathway informatics platform from the Institute of Medicinal Molecular Design, the Japan-based institute said today.

 

EMBL will use KeyMolnet at its main laboratory in Heidelberg, Germany, and at its outstations.

 

KeyMolnet is a database of information on the relationships among genes, molecules, diseases, pathways, and drugs that have been manually curated from literature by IMMD biologists.

 

The Genomics and Chemical Biology Core Facilities will provide KeyMolnet access to EMBL's research community and collaborators.

 

Financial details were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.